CareDx Inc (CDNA) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Diagnostics & Research industry.
Over the past 4 years, CareDx Inc has achieved a revenue compound annual growth rate (CAGR) of 14.8%.
Historical revenue and profitability trends for CareDx Inc
The chart above illustrates CareDx Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of CareDx Inc's business.
How efficiently CareDx Inc converts revenue into profit
Profit margins reveal how much of each dollar of revenue CareDx Inc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project CareDx Inc to continue growing earnings in the coming year. The consensus analyst rating is 4.125 based on 8 analysts.
Based on our comprehensive analysis, CareDx Inc (CDNA) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of CareDx Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how CareDx Inc stacks up against similar companies
Explore growth analysis for top stocks
Related: CDNA Valuation, CDNA Dividend, CDNA Financial Health
Compare: CDNA vs AAPL, CDNA vs MSFT, CDNA vs GOOGL